Alzheimer's disease often presents with several comorbidities, exacerbating its complex impact on patients. Common comorbid conditions include cardiovascular diseases like hypertension and heart disease, which can contribute to cognitive decline. Depression and anxiety are prevalent among Alzheimer's patients, further complicating their management and quality of life. Diabetes is another significant comorbidity, as insulin resistance may accelerate neurodegeneration. These conditions not only worsen cognitive symptoms but also pose challenges for treatment and care strategies. Addressing Alzheimer's comorbidities requires a holistic approach that integrates medical, psychological, and lifestyle interventions to manage symptoms effectively and improve overall patient outcomes.
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States